Volgen
Hizra Farrukh
Hizra Farrukh
Dana Farber Cancer Institute, Harvard Medical School
Geverifieerd e-mailadres voor dfci.harvard.edu
Titel
Geciteerd door
Geciteerd door
Jaar
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
K Pan, H Farrukh, VCSR Chittepu, H Xu, C Pan, Z Zhu
Journal of Experimental & Clinical Cancer Research 41 (1), 119, 2022
4332022
Prevalence of depression and anxiety amongst cancer patients in a hospital setting: a cross-sectional study
A Khalil, M Faheem, A Fahim, H Innocent, Z Mansoor, S Rizvi, H Farrukh
Psychiatry journal 2016, 2016
852016
Increasing cure rates of solid tumors by immune checkpoint inhibitors
W Ma, R Xue, Z Zhu, H Farrukh, W Song, T Li, L Zheng, C Pan
Experimental Hematology & Oncology 12 (1), 10, 2023
612023
Phototherapy with cancer-specific nanoporphyrin potentiates immunotherapy in bladder cancer
Z Zhu, AH Ma, H Zhang, TY Lin, X Xue, H Farrukh, S Zhu, W Shi, R Yuan, ...
Clinical Cancer Research 28 (21), 4820-4831, 2022
232022
A phase I dose-escalation clinical trial with PLZ4-coated paclitaxel-loaded micelles (PPM) in patients with recurrent or refractory non-myoinvasive bladder cancer.
H Farrukh, Z Zhu, J Garisto Risco, KS Lam, C Pan
Journal of Clinical Oncology 41 (16_suppl), TPS4615-TPS4615, 2023
42023
A phase II trial with copanlisib plus avelumab as maintenance therapy for metastatic bladder cancer after platinum-based chemotherapy.
H Farrukh, Z Zhu, S Zhu, RB Montgomery, JJ Meeks, DJ VanderWeele, ...
Journal of Clinical Oncology 41 (16_suppl), TPS4610-TPS4610, 2023
22023
P08. 04 Phototherapy with cancer-specific nanoporphyrin potentiates immunotherapy in bladder cancer
C Pan, Z Zhu, A Ma, H Zhang, T Lin, H Farrukh, Y Li, K Lam
Journal for ImmunoTherapy of Cancer 10 (Suppl 1), 2022
12022
Clinical Pattern of Stroke and Distributions According to Age, Gender and Potential Risk Factors.
AU Slam, MR Ejaz Rana, MU Arshad, S Khatoon, F Khalid, M Ashraf, ...
Journal of Rawalpindi Medical College 22, 2018
12018
Clinical Pattern of Stroke and Distributions According to Age, Gender and Potential Risk Factors
FK Khatoon, M Ashraf, S Abbas, H Farrukh
1*
06.04 Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
C Pan, Z Zhu, S Zhu, A Ma, V Chittepu, H Farrukh, F Cheng
Journal for ImmunoTherapy of Cancer 10 (Suppl 1), 2022
2022
Novel Therapies for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma: A Review of Clinical Trials
A Iftikhar, M Ahmad, P Pachika, F Razzaq, MAA Ali, H Farrukh, A Latif, ...
Blood 136, 43-44, 2020
2020
Efficacy of Isatuximab on Surrogate Endpoints in Multiple Myeloma; A Systematic Review
MAU Din, SA Hussain, H Farrukh, F Pasha, SM Abdullah, I Waris, ...
Blood 136, 34, 2020
2020
Research Article Prevalence of Depression and Anxiety amongst Cancer Patients in a Hospital Setting: A Cross-Sectional Study
A Khalil, M Faheem, A Fahim, H Innocent, Z Mansoor, S Rizvi, H Farrukh
2016
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–13